Femtobiomed (XKRX:327610) Net Change in Cash : ₩693.7 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Femtobiomed's Net Change in Cash for the six months ended in Dec. 2024 was ₩693.7 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩693.7 Mil.

Femtobiomed Net Change in Cash Historical Data

The historical data trend for Femtobiomed's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed Net Change in Cash Chart

Femtobiomed Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

76.01

2,372.57

-698.15

-487.06

693.69

Femtobiomed Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Net Change in Cash	Get a 7-Day Free Trial			76.01	2,372.57	-698.15	-487.06	693.69

Femtobiomed Net Change in Cash Calculation

Femtobiomed's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-2057.457	+	-39.929	+	2786.847	+	4.233
	=	693.7

Femtobiomed's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -2057.457 + -39.929 + 2786.847 + 4.233

= 693.7

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩693.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Femtobiomed Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Femtobiomed's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Femtobiomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Net Change in Cash

Comparable Companies

XKRX:446440 XKRX:343090 XKRX:344860 XKRX:199730 XKRX:215380 XKRX:065650 XKRX:298060 XKRX:179530 XKRX:322970 XKRX:188260 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX

Traded in Other Exchanges

N/A

Address

17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487

Website

https://www.femtobiomed.com

Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed Headlines

No Headlines